Ambrisentan Tablet, Film Coated
Product Images NDC 50090-7671

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ambrisentan (NDC 50090-7671). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ambrisentan-fig1.jpg (Ambrisentan Fig1)

Ambrisentan-fig1.jpg (Ambrisentan Fig1)
This text lists interacting drugs and includes fold change and 90% CI values. The drugs mentioned are Cyclosporine, Mycophenolate Mofetil, Ketoconazole, Omeprazole, Ritonavir, Tacrolimus, and Wartarin. The text seems to be part of a study or report discussing the pharmacokinetics (PK) of these drugs and their interaction with ambrisentan. The mentioned values appear to show changes relative to ambrisentan alone.*
FDA Label Image

Ambrisentan-fig2.jpg (Ambrisentan Fig2)

Ambrisentan-fig2.jpg (Ambrisentan Fig2)
This is a list of interacting drugs including Cyclosporine, Digoxin, Ethinylestradiol, Norethindrone, Mycophenolic acid, Ritonavir, Sildenafil, and others. The text also mentions terms like AUC, Cmax, Emax, AUEC, Fold Change, and 90% Confidence Level, which are likely related to pharmacokinetic studies or drug interactions. The data seems to show values at specific time points (00, 05, 15, 20, 25, 30) and may be comparing changes relative to each drug alone.*
FDA Label Image

Ambrisentan-fig3.jpg (Ambrisentan Fig3)

Ambrisentan-fig3.jpg (Ambrisentan Fig3)
This text appears to be a comparison chart showing data for two groups labeled as ARIES -1 and ARIES -2. The data includes measurements at baseline, week 4, week 8, and week 12 for parameters like "Placebo," "-efcee," and "- 5 9." The values in the chart seem to be numerical measurements for different variables in the study.*
FDA Label Image

Figure 5 Time To Clinical Worsening (aries-1 And Aries-2) (Ambrisentan Fig4)

FDA Label Image

Ambrisentan-str.jpg (Ambrisentan Str)

FDA Label Image

Label Image (Lbl500907671)

Label Image (Lbl500907671)
This is a product label providing information about a 5mg tablet. The label includes details such as the product code "eti06-0" and that each pack contains 30 tablets. The product seems to be related to stone or health supplements.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.